Multiple sclerosis: open trials in Australia

15 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Neurology Network, Melbourne
Registry updated 2026-11-03
NCT06782490
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Trial Treatment · Phase 2 · Celgene
Box Hill Hospital, Box Hill · Austin Health, Heidelberg · Menzies Research Institute, Hobart · Centre for Neuroscience Innovation, Kent Town · Perron Institute, Nedlands · John Hunter Hospital, Newcastle · The Royal Melbourne Hospital, Parkville · University of Sydney - Brain and Mind Research Institute (BMRI), Sydney
Registry updated 2026-10-27
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Southern Neurology Suite 2, Kogarah
Registry updated 2026-10-27
NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Liverpool · Novartis Investigative Site, Melbourne · Novartis Investigative Site, Parkville · Novartis Investigative Site, St Leonards
Registry updated 2026-10-26
NCT07304154
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Trial Treatment · Phase 1 · Kite, A Gilead Company
Concord Repatriation General Hospital, Sydney · Corner Hawkesbury Road and Darcy Road, Westmead
Registry updated 2026-10-19
NCT07875309
An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online
Trial Treatment · University of Melbourne
Royal Melbourne Hospital, Melbourne
Registry updated 2026-10-15
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Clayton · Novartis Investigative Site, Heidelberg · Novartis Investigative Site, Kogarah · Novartis Investigative Site, Murdoch · Novartis Investigative Site, New Lambton Heights · Novartis Investigative Site, Southport · Novartis Investigative Site, Westmead
Registry updated 2026-10-13
NCT07282574
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Trial Treatment · Phase 2 · Hoffmann-La Roche
Box Hill Hospital, Box Hill · Brain and Mind Centre, Camperdown · Austin Health, Heidelberg · Southern Neurology, Kogarah · John Hunter Hospital, New Lambton Heights
Registry updated 2026-10-07
NCT07826689
A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis
Trial Treatment · Phase 1/2 · Progentos Therapeutics
CMAX Clinical Research, Adelaide
Registry updated 2026-09-29
NCT06408259
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Royal Children's Hospital, Melbourne
Registry updated 2026-09-10
NCT07224373
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Trial Treatment · Phase 1 · AstraZeneca
Research Site, Liverpool · Research Site, Melbourne · Research Site, Waratah
Registry updated 2026-08-25
NCT05658497
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Research · Biogen
Austin Hospital, Heidelberg
Registry updated 2026-08-11
NCT07085507
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients
Trial Treatment · Phase 1/2 · Vidya Therapeutics Inc
CMAX, Adelaide
Registry updated 2026-07-21
NCT06735248
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
Trial Treatment · Phase 2 · ModernaTX, Inc.
University of the Sunshine Coast Clinical Trials, Birtinya
Registry updated 2026-06-15
NCT05620940
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Trial Treatment · Phase 1 · Inventage Lab., Inc.
Nucleus Network, Herston
Registry updated 2025-09-15

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error